DK3035912T3 - Farmaceutisk sammensætning til en langvarig frigivelse af lanreotid - Google Patents
Farmaceutisk sammensætning til en langvarig frigivelse af lanreotid Download PDFInfo
- Publication number
- DK3035912T3 DK3035912T3 DK14736812.0T DK14736812T DK3035912T3 DK 3035912 T3 DK3035912 T3 DK 3035912T3 DK 14736812 T DK14736812 T DK 14736812T DK 3035912 T3 DK3035912 T3 DK 3035912T3
- Authority
- DK
- Denmark
- Prior art keywords
- lanreotide
- pharmaceutical composition
- sustained release
- sustained
- release
- Prior art date
Links
- PUDHBTGHUJUUFI-SCTWWAJVSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2r)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-p Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)=O)C(C)C)C1=CC=C(O)C=C1 PUDHBTGHUJUUFI-SCTWWAJVSA-N 0.000 title 1
- 229960002437 lanreotide Drugs 0.000 title 1
- 108010021336 lanreotide Proteins 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000013268 sustained release Methods 0.000 title 1
- 239000012730 sustained-release form Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13290156.2A EP2823808A1 (en) | 2013-07-09 | 2013-07-09 | Pharmaceutical composition for a sustained release of lanreotide |
| PCT/EP2014/064586 WO2015004125A1 (en) | 2013-07-09 | 2014-07-08 | Pharmaceutical composition for a sustained release of lanreotide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3035912T3 true DK3035912T3 (da) | 2022-10-03 |
Family
ID=48832841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14736812.0T DK3035912T3 (da) | 2013-07-09 | 2014-07-08 | Farmaceutisk sammensætning til en langvarig frigivelse af lanreotid |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US10543249B2 (da) |
| EP (2) | EP2823808A1 (da) |
| JP (2) | JP2016523945A (da) |
| KR (1) | KR102232410B1 (da) |
| CN (1) | CN105392470A (da) |
| AR (1) | AR096854A1 (da) |
| AU (1) | AU2014289332B2 (da) |
| CA (1) | CA2917098A1 (da) |
| DK (1) | DK3035912T3 (da) |
| EA (1) | EA034224B1 (da) |
| ES (1) | ES2928676T3 (da) |
| HU (1) | HUE060497T2 (da) |
| IL (1) | IL243027A0 (da) |
| MX (1) | MX367926B (da) |
| PL (1) | PL3035912T3 (da) |
| PT (1) | PT3035912T (da) |
| SG (1) | SG11201510698QA (da) |
| TW (1) | TWI715520B (da) |
| UA (1) | UA116569C2 (da) |
| WO (1) | WO2015004125A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109381695A (zh) * | 2017-08-09 | 2019-02-26 | 武汉武药科技有限公司 | 一种门冬氨酸帕瑞肽注射液及其制备方法和用途 |
| FR3079421B1 (fr) * | 2018-03-28 | 2024-11-15 | Edix Sa | Presentations injectables, seringues et compositions a liberation prolongee et/ou controlee de lanreotide |
| MD3811927T2 (ro) | 2019-10-24 | 2022-03-31 | Sun Pharmaceutical Ind Ltd | O formă de dozaj parenterală stabilă de acetat de cetrorelix |
| EP4192427B1 (en) | 2020-08-07 | 2025-11-05 | Pharmathen S.A. | Process and apparatus for preparing viscous pharmaceutical formulations |
| LU101974B1 (en) | 2020-08-07 | 2022-02-07 | Pharmathen Sa | Process and apparatus for preparing viscous pharmaceutical formulations |
| GR1010059B (el) * | 2020-08-10 | 2021-08-13 | Φαρματεν Α.Β.Ε.Ε. | Διαδικασια και συσκευη για την παρασκευη παχυρευστων φαρμακοτεχνικων μορφων |
| MX2024006112A (es) * | 2021-11-22 | 2024-07-30 | SpecGx LLC | Composicion farmaceutica inyectable de liberacion sostenida. |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US271189A (en) * | 1883-01-23 | beals | ||
| US5595760A (en) | 1994-09-02 | 1997-01-21 | Delab | Sustained release of peptides from pharmaceutical compositions |
| CN101590011A (zh) * | 1994-09-02 | 2009-12-02 | 科学研究与运用咨询公司 | 肽从药物组合物中的持续释放 |
| CA2259403A1 (en) * | 1996-07-03 | 1998-01-08 | Alza Corporation | Non-aqueous protic peptide formulations |
| FR2762319A1 (fr) | 1997-04-18 | 1998-10-23 | Pharma Biotech | Microcapsules presentant une liberation prolongee et leur procede de preparation |
| FR2776520B1 (fr) | 1998-03-25 | 2000-05-05 | Sod Conseils Rech Applic | Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation |
| IT1318539B1 (it) * | 2000-05-26 | 2003-08-27 | Italfarmaco Spa | Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente |
| US7098305B2 (en) | 2001-09-06 | 2006-08-29 | Ardana Bioscience Limited | Sustained release of microcrystalline peptide suspensions |
| CN1415378A (zh) | 2002-10-22 | 2003-05-07 | 南京长澳医药科技有限公司 | 生长抑素冻干粉针及其制备工艺 |
| WO2004103342A2 (en) | 2003-05-16 | 2004-12-02 | Alkermes Controlled Therapeutics, Inc. | Injectable sustained release compositions |
| WO2006022301A1 (ja) * | 2004-08-24 | 2006-03-02 | Daiichi Asubio Pharma Co., Ltd. | 生理活性ペプチド液状製剤 |
| US20090092650A1 (en) * | 2004-12-15 | 2009-04-09 | Warren Stephen L | Sustained Delivery Formulations of Octreotide Compounds |
| GB0428151D0 (en) * | 2004-12-22 | 2005-01-26 | Novartis Ag | Organic compounds |
| KR100983746B1 (ko) * | 2005-01-14 | 2010-09-24 | 카무러스 에이비 | 소마토스타틴 유사 제형 |
| US8158152B2 (en) | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| GB0711656D0 (en) | 2007-06-15 | 2007-07-25 | Camurus Ab | Formulations |
| FI120057B (fi) * | 2007-07-13 | 2009-06-15 | Andritz Oy | Laite ja menetelmä lipeäruiskun puhdistamiseksi ja jäähdyttämiseksi |
| EP2192915A1 (en) | 2007-09-11 | 2010-06-09 | Mondobiotech Laboratories AG | Therapeutic uses of peptides ysaypdsvpmms and wmnstgftkvcgappc |
| US20090181068A1 (en) * | 2008-01-14 | 2009-07-16 | Dunn Richard L | Low Viscosity Liquid Polymeric Delivery System |
| JP5791278B2 (ja) * | 2008-01-30 | 2015-10-07 | ノバルティス アーゲー | オクトレオチドおよび３種の線状ポリラクチド−コ−グリコリドポリマーを含む徐放性製剤 |
| MX347056B (es) | 2008-08-12 | 2017-04-10 | Novartis Ag | Composiciones farmaceuticas. |
| EP2168983A1 (fr) | 2008-09-30 | 2010-03-31 | Ipsen Pharma | Nouveaux composés octapeptidiques et leur utilisation thérapeutique |
| EP2376060B1 (en) * | 2008-12-15 | 2012-09-19 | Novartis AG | Nanoparticle compositions |
| EP2408472A4 (en) * | 2009-03-18 | 2013-01-02 | Univ Leland Stanford Junior | USE OF SOMATOSTATIN OR ANALOG IN COMBINATION WITH EXTERNAL RADIOTHERAPY |
| TR201809874T4 (tr) * | 2010-01-13 | 2018-07-23 | Ipsen Pharma Sas | Somatostati̇n analoglarinin sürekli̇ salimi i̇çi̇n farmasöti̇k bi̇leşi̇mleri̇n hazirlanmasi süreci̇. |
| AU2012348640B2 (en) * | 2011-12-05 | 2016-07-21 | Camurus Ab | Robust controlled-release peptide formulations |
-
2013
- 2013-07-09 EP EP13290156.2A patent/EP2823808A1/en not_active Ceased
-
2014
- 2014-07-08 EP EP14736812.0A patent/EP3035912B1/en active Active
- 2014-07-08 WO PCT/EP2014/064586 patent/WO2015004125A1/en not_active Ceased
- 2014-07-08 PL PL14736812.0T patent/PL3035912T3/pl unknown
- 2014-07-08 CA CA2917098A patent/CA2917098A1/en not_active Abandoned
- 2014-07-08 DK DK14736812.0T patent/DK3035912T3/da active
- 2014-07-08 MX MX2016000294A patent/MX367926B/es active IP Right Grant
- 2014-07-08 AR ARP140102537A patent/AR096854A1/es not_active Application Discontinuation
- 2014-07-08 KR KR1020167003036A patent/KR102232410B1/ko active Active
- 2014-07-08 TW TW103123446A patent/TWI715520B/zh active
- 2014-07-08 ES ES14736812T patent/ES2928676T3/es active Active
- 2014-07-08 US US14/903,010 patent/US10543249B2/en active Active
- 2014-07-08 HU HUE14736812A patent/HUE060497T2/hu unknown
- 2014-07-08 AU AU2014289332A patent/AU2014289332B2/en active Active
- 2014-07-08 EA EA201690191A patent/EA034224B1/ru not_active IP Right Cessation
- 2014-07-08 SG SG11201510698QA patent/SG11201510698QA/en unknown
- 2014-07-08 PT PT147368120T patent/PT3035912T/pt unknown
- 2014-07-08 CN CN201480038507.4A patent/CN105392470A/zh active Pending
- 2014-07-08 JP JP2016524794A patent/JP2016523945A/ja active Pending
- 2014-08-07 UA UAA201601113A patent/UA116569C2/uk unknown
-
2015
- 2015-12-21 IL IL243027A patent/IL243027A0/en unknown
-
2019
- 2019-02-25 JP JP2019032085A patent/JP6811270B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20160030232A (ko) | 2016-03-16 |
| SG11201510698QA (en) | 2016-01-28 |
| EP3035912B1 (en) | 2022-08-31 |
| KR102232410B1 (ko) | 2021-03-29 |
| PL3035912T3 (pl) | 2022-12-05 |
| TW201536346A (zh) | 2015-10-01 |
| AU2014289332A1 (en) | 2016-02-11 |
| TWI715520B (zh) | 2021-01-11 |
| JP6811270B2 (ja) | 2021-01-13 |
| JP2016523945A (ja) | 2016-08-12 |
| IL243027A0 (en) | 2016-02-29 |
| EP2823808A1 (en) | 2015-01-14 |
| EA201690191A1 (ru) | 2016-06-30 |
| JP2019073564A (ja) | 2019-05-16 |
| MX2016000294A (es) | 2016-04-28 |
| US20160151447A1 (en) | 2016-06-02 |
| HUE060497T2 (hu) | 2023-03-28 |
| PT3035912T (pt) | 2022-10-26 |
| ES2928676T3 (es) | 2022-11-21 |
| WO2015004125A1 (en) | 2015-01-15 |
| EP3035912A1 (en) | 2016-06-29 |
| CA2917098A1 (en) | 2015-01-15 |
| UA116569C2 (uk) | 2018-04-10 |
| US10543249B2 (en) | 2020-01-28 |
| AU2014289332B2 (en) | 2019-07-11 |
| AR096854A1 (es) | 2016-02-03 |
| CN105392470A (zh) | 2016-03-09 |
| EA034224B1 (ru) | 2020-01-20 |
| MX367926B (es) | 2019-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3454346T3 (da) | Anordning til cylotronfremstilling af technetium-99m | |
| DK3030262T3 (da) | Kombineret farmaceutisk sammensætning | |
| DK2968221T3 (da) | Farmaceutisk sammensætning af s-ketaminhydrochlorid | |
| DK2968529T3 (da) | Fremstilling af jordnøddeformuleringer til oral desensibilisering | |
| DK3083540T3 (da) | Fremgangsmåde til fremstilling af substituerede phenoxyphenylketoner | |
| DK3669913T3 (da) | Anordning til indgivelse af lægemidler | |
| DK3848027T3 (da) | Octahydro-kondenserede azadecalinglucocorticoidreceptormodulatorer | |
| DK2961388T3 (da) | Kombinationer af lægemidler | |
| DK2953904T3 (da) | Fremgangsmåde til kontrolleret fremstilling af et biocid | |
| DK2970389T3 (da) | Farmaceutiske forbindelser | |
| DK3013544T3 (da) | Fremgangsmåde til betonfremstilling | |
| DK3016991T3 (da) | Sammensætninger til formning af væsker | |
| EP2958994A4 (en) | Vaccine composition | |
| DK3010895T3 (da) | Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner | |
| IL244260A0 (en) | A delayed release drug formulation | |
| EP2961397A4 (en) | TRANSDERMAL FORMULATIONS | |
| DK2919777T3 (da) | Transmukosal afgivelse af tocotrienol | |
| DK2968146T3 (da) | Liposomsammensætning med kontrolleret lægemiddelfrigivelse | |
| DK3035912T3 (da) | Farmaceutisk sammensætning til en langvarig frigivelse af lanreotid | |
| DK2967936T3 (da) | Skrå stent | |
| DK3357522T3 (da) | Coatet medicinsk genstand til lægemiddelsfrigivelse | |
| DK2732707T3 (da) | Fremgangsmåde til fremstilling af en sammensætning indeholdende caseinomacropeptid | |
| DK2767289T3 (da) | Forbedret frigivelse af en gavnlig substans fra en bolus | |
| DK3082762T3 (da) | Langtidsvirkende ketoprofensammensætninger | |
| DK3052212T3 (da) | Fremgangsmåde til afluftning af en væske |